Pennisi Maria Grazia, Persichetti Maria Flaminia
Dipartimento di Scienze Veterinarie, Università di Messina - Polo Universitario Annunziata, 98168 Messina, Italy.
Dipartimento di Scienze Veterinarie, Università di Messina - Polo Universitario Annunziata, 98168 Messina, Italy; Istituto Zooprofilattico Sperimentale della Sicilia "A. Mirri" - Via Gino Marinuzzi 3, 90129 Palermo, Italy.
Vet Parasitol. 2018 Feb 15;251:131-137. doi: 10.1016/j.vetpar.2018.01.012. Epub 2018 Feb 2.
Leishmania infantum is a vector-borne zoonotic disease transmitted by phlebotomine sand flies and dogs are considered the main reservoir of the parasite. Feline leishmaniosis (FeL) caused by L. infantum is an emergent feline disease more and more frequently reported in endemic areas. This review summarizes current knowledge focusing similarities and differences with canine leishmaniosis (CanL). Cats are infected by the same Leishmania species than dogs but prevalence of the infection is lower and cases of disease are less frequently reported. Scarce information is available on adaptive immune response of cats naturally exposed to L. infantum infection and mechanisms responsible for susceptibility or resistance of feline hosts. However, about half of clinical cases of FeL are reported in cats with possible impaired immunocompetence. Coinfections or comorbidities are frequently detected in sick cats and they can contribute to a misrepresentation of clinical FeL albeit lesions associated with the presence of the parasite have been detected in skin, lymph nodes, spleen, bone marrow, liver, oral mucosa, stomach, large bowel, kidney, nasal exudate, lung, eye. As for dogs, skin or mucocutaneous lesions are the most common reason for veterinary consultation and finding on physical examination in cats with leishmaniosis. Molecular investigations of Leishmania DNA and anti- Leishmania antibody detection are largely used with the same methodologies for both CanL and FeL, however few information is available about their diagnostic performance in feline hosts. Treatment of cats with clinical FeL is still empirically based and off label by using the most common drugs prescribed to dogs. Life expectancy of cats with clinical FeL is usually good unless concurrent conditions or complications occur and prognosis does not seem significantly influenced by therapy or retroviral coinfection. According to current knowledge, cats can play a role as additional reservoir host of L. infantum and, in a « One Health » perspective, preventative measures should be taken. In conclusion, albeit feline infection and the associated cat disease caused by L. infantum is increasingly reported in endemic areas and have many similarities with CanL, consolidated evidence-based knowledge is not available and we cannot exclude that important differences between dogs and cats exist about transmission, immunopathogenesis and best practice for management and prevention.
婴儿利什曼原虫病是一种通过白蛉传播的人畜共患病,狗被认为是该寄生虫的主要宿主。由婴儿利什曼原虫引起的猫利什曼病(FeL)是一种在流行地区越来越频繁报道的新兴猫科疾病。本综述总结了当前的知识,重点关注与犬利什曼病(CanL)的异同。猫与狗感染的是同一种利什曼原虫,但感染率较低,疾病病例的报道也较少。关于自然暴露于婴儿利什曼原虫感染的猫的适应性免疫反应以及猫宿主易感性或抵抗力的机制,目前信息匮乏。然而,约一半的FeL临床病例报告于免疫功能可能受损的猫。患病猫中经常检测到合并感染或共病,它们可能导致临床FeL的误诊,尽管在皮肤、淋巴结、脾脏、骨髓、肝脏、口腔黏膜、胃、大肠、肾脏、鼻分泌物、肺、眼睛中已检测到与寄生虫存在相关的病变。与狗一样,皮肤或黏膜皮肤病变是猫利什曼病患者兽医咨询和体格检查中最常见的原因。利什曼原虫DNA的分子研究和抗利什曼原虫抗体检测在CanL和FeL中大多采用相同的方法,但关于它们在猫宿主中的诊断性能的信息很少。临床FeL猫的治疗仍然基于经验,使用给狗开的最常用药物属于超适应症用药。临床FeL猫的预期寿命通常较好,除非出现并发疾病或并发症,并且预后似乎不受治疗或逆转录病毒合并感染的显著影响。根据目前的知识,猫可以作为婴儿利什曼原虫的额外宿主,从“同一健康”的角度来看,应采取预防措施。总之,尽管在流行地区由婴儿利什曼原虫引起的猫感染及相关猫病越来越多地被报道,且与CanL有许多相似之处,但目前尚无确凿的循证知识,我们不能排除在传播、免疫发病机制以及管理和预防的最佳实践方面,狗和猫之间存在重要差异。